Okar Agency Pharmaceutical Import Profile — Sierra Leone (DGFT 2022–2026)

Name: Okar Agency Pharmaceutical Import Records from India — 2 Products, $550.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Okar Agency — Pharmaceutical Importer Profile (2026) | 2 Products, $550.0K Trade | TransData Nexus

Okar Agency

Pharmaceutical Importer · Sierra Leone · Antibiotics Focus · $550.0K Total Trade · DGFT Verified

Okar Agency is a pharmaceutical importer based in Sierra Leone with a total trade value of $550.0K across 2 products in 2 therapeutic categories. Based on 11 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Okar Agency sources from 5 verified Indian suppliers, with Mednext Biotech Limited accounting for 68.5% of imports.

Okar Agency — Import Portfolio & Supplier Network

Okar Agency import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Okar Agency?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mednext Biotech Limited	$807.2K	392	68.5%
Narang Medical Limited	$240.1K	78	20.4%
Kwality Pharmaceuticals Limited	$82.4K

What Formulations Does Okar Agency Import?

Formulation	Value	Ships
Bevac INJ.(adult)	$142.5K	3
Ciprofloxacin 2MG/ML solution for	$129.9K	3
Metronidazole 5MG/ML injection bottle	$103.6K	3
Cotrimoxazole TAB 480MG (tax	$67.5K	2
Stk nomics- streptokinase 1.5 miu	$30.9K	3
Ketamine hydrochloride injection (batchno & other details as per inv & packinglist)	$23.7K	2
Pharmaceutical finished formulations	$23.3K	1
Nitroglycerin 0 4MG dose tax inv export 22 23 160 dt 31 03	$22.2K	1
Naloxone injection tax inv export 22 23 151 dt 29 03	$20.0K	2
Gelatin modified 4% intravenous	$17.1K	3
Rinhep-5000iu, lot no.	$16.0K	2
Tablet acefan 500 Each tablet	$15.7K	1
Chloramphenicol sodium succinate 1 g	$15.6K	1
Folic acid TAB 5MG (tax	$15.5K	2
Quinine sulphate 300 MG Film-Coated	$14.5K	1

Okar Agency imports 346 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ciprofloxacin	Antibiotics	$300.0K	6	0.1%	11
2	Ofloxacin	Advanced Antibiotics	$250.0K	5	0.1%	8

Okar Agency imports 2 pharmaceutical products across 2 categories into Sierra Leone totaling $550.0K.

Okar Agency — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Okar Agency is a pharmaceutical importer based in Freetown, Sierra Leone, specializing in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established to meet the nation's healthcare needs, the company plays a pivotal role in ensuring the availability of essential medications. Sierra Leone lacks domestic pharmaceutical manufacturing capabilities, making imports crucial for its healthcare system.

The agency operates as a primary wholesaler, sourcing a diverse range of pharmaceutical products to supply local pharmacies, hospitals, and clinics. By importing directly from reputable manufacturers, Okar Agency ensures the quality and efficacy of the medications distributed within Sierra Leone. This direct import model allows the company to maintain control over product quality and pricing, thereby enhancing its competitiveness in the market.

2Distribution Network

Okar Agency's distribution network is strategically designed to cover the entire Sierra Leonean market. While specific warehouse locations are not publicly disclosed, the company utilizes a centralized distribution system to efficiently manage inventory and fulfill orders. This centralized approach enables rapid response times and ensures that pharmaceutical products are readily available to meet the demands of healthcare providers across the country.

The agency's logistics capabilities are robust, leveraging partnerships with established shipping and freight companies to facilitate timely deliveries. By maintaining strong relationships with these logistics partners, Okar Agency can navigate the complexities of international shipping, including customs clearance and regulatory compliance, ensuring that products arrive in optimal condition.

3Industry Role

In Sierra Leone's pharmaceutical supply chain, Okar Agency functions as a primary wholesaler. The company imports finished pharmaceutical formulations from India, which are then distributed to local pharmacies, hospitals, and clinics. This role is critical, given the absence of domestic pharmaceutical manufacturing, as it ensures a steady supply of essential medications to meet the healthcare needs of the population.

By acting as a direct importer and distributor, Okar Agency bridges the gap between international pharmaceutical manufacturers and the Sierra Leonean market. This position allows the company to influence the availability and pricing of medications, thereby impacting the overall healthcare landscape in the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Okar Agency

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Okar Agency's sourcing strategy is highly concentrated, with a significant majority of its pharmaceutical imports originating from India. The company's total import value from India stands at $550,000 USD, encompassing 11 shipments and two primary products: Ciprofloxacin and Ofloxacin. This concentration indicates a strategic choice to rely on a single source for these specific medications, likely due to favorable pricing, quality, and reliability associated with Indian suppliers.

However, this sourcing concentration also presents potential risks. Dependence on a single supplier or country can expose Okar Agency to supply chain disruptions caused by geopolitical issues, regulatory changes, or logistical challenges. To mitigate these risks, the company may consider diversifying its supplier base and exploring alternative sources for its pharmaceutical imports.

2Supply Chain Resilience

Okar Agency's supply chain resilience is closely tied to its sourcing practices. The company's reliance on a limited number of Indian suppliers—five in total—suggests a streamlined supply chain but also highlights potential vulnerabilities. The concentration of imports in two therapeutic categories, Antibiotics and Advanced Antibiotics, further underscores this focus.

To enhance supply chain resilience, Okar Agency could explore establishing relationships with additional suppliers, both within India and internationally. Diversifying the supplier base would reduce dependency on a few sources and provide alternative options in case of disruptions. Additionally, expanding the range of imported formulations beyond the current two categories could help buffer against market fluctuations and changing healthcare demands.

Importing Pharmaceuticals into Sierra Leone — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sierra Leone

1Regulatory Authority & Framework

The Pharmacy Board of Sierra Leone (PBSL) serves as the primary regulatory authority overseeing the pharmaceutical sector in the country. Established under the Pharmacy and Drugs Act of 2001, the PBSL is responsible for regulating the practice of pharmacy, ensuring the safety, efficacy, and quality of all drugs, medical devices, cosmetics, and nutritional agents.

Key functions of the PBSL include drug evaluation and registration, licensing, import control, market and quality control, pharmacovigilance, clinical trials, and drug promotion and advertising. These responsibilities are crucial for maintaining public health standards and ensuring that pharmaceutical products meet the required regulatory criteria before entering the market.

2Import Licensing & GMP

Importers of pharmaceutical products into Sierra Leone must obtain the necessary licenses and permits from the PBSL. This includes Import Permits and Clearance Permits, which are mandatory for all pharmaceutical imports. The PBSL's Factory Inspectorate & Import Control Department oversees the issuance of these permits and ensures compliance with regulatory standards. (pharmacyboard.gov.sl)

Additionally, the PBSL requires that all imported pharmaceutical products comply with Good Manufacturing Practices (GMP). GMP certification ensures that products are consistently produced and controlled according to quality standards. Importers must verify that their suppliers hold valid GMP certifications recognized by the PBSL to facilitate the importation process. (pharmacyboard.gov.sl)

Okar Agency — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Okar Agency's focus on antibiotics, particularly Ciprofloxacin and Ofloxacin, aligns with the prevalent healthcare needs in Sierra Leone. Antibiotics are essential in treating various infections, and the demand for these medications is consistently high. By concentrating on these therapeutic areas, Okar Agency ensures that it meets a critical segment of the market, thereby strengthening its position as a key supplier.

The choice to import these specific antibiotics may also be driven by factors such as cost-effectiveness, availability, and the therapeutic efficacy of the products. By focusing on a targeted product range, Okar Agency can optimize its supply chain and inventory management, ensuring that it can meet demand without overextending its resources.

2Sourcing Profile

Okar Agency's sourcing strategy is centered on importing generic drugs from India, a country known for its robust pharmaceutical manufacturing sector. The agency's preference for finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, indicates a focus on ready-to-use products that can be directly distributed to healthcare providers.

India's pharmaceutical industry offers a wide range of generic medications that are both cost-effective and of high quality, making it an attractive sourcing destination for Okar Agency. By importing from India, the agency can leverage competitive pricing and a diverse product portfolio, ensuring that it can meet the varied needs of the Sierra Leonean market.

Seller's Guide — How to Become a Supplier to Okar Agency

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Sierra Leone

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Okar Agency

What products does Okar Agency import from India?

Okar Agency imports 2 pharmaceutical products across 2 categories. Top imports: Ciprofloxacin ($300.0K), Ofloxacin ($250.0K).

Who supplies pharmaceuticals to Okar Agency from India?

Okar Agency sources from 5 verified Indian suppliers. The primary supplier is Mednext Biotech Limited (68.5% of imports, $807.2K).

What is Okar Agency's total pharmaceutical import value?

Okar Agency's total pharmaceutical import value from India is $550.0K, based on 11 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Okar Agency focus on?

Okar Agency imports across 2 categories. The largest: Antibiotics (54.5%), Advanced Antibiotics (45.5%).

Get Full Okar Agency Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.